Skip to contentC
Cannabis Suisse Corp.
C
CSUICannabis Suisse Corp. Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$0.00$0.00derived−100.0% vs Q4 2024 Net Income$44.37K$44.37KderivedN/M vs Q4 2024 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cannabis Suisse Corp. · CIK 1680132 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$54,077N/M Operating Cash Flowderived-$9,200N/M ended May 31, 2025 · filed Sep 12, 2025 · 104 d after period end